Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

1.

Bacillus anthracis infection in irradiated mice: susceptibility, protection, and therapy.

Elliott TB, Brook I, Harding RA, Bouhaouala SS, Peacock SJ, Knudson GB.

Mil Med. 2002 Feb;167(2 Suppl):103-4. No abstract available.

PMID:
11873486
2.

Clindamycin and quinolone therapy for Bacillus anthracis Sterne infection in 60Co-gamma-photon-irradiated and sham-irradiated mice.

Brook I, Germana A, Giraldo DE, Camp-Hyde TD, Bolduc DL, Foriska MA, Elliott TB, Thakar JH, Shoemaker MO, Jackson WE, Ledney GD.

J Antimicrob Chemother. 2005 Dec;56(6):1074-80. Epub 2005 Oct 20.

PMID:
16239289
3.

Significant passive protective effect against anthrax by antibody to Bacillus anthracis inactivated spores that lack two virulence plasmids.

Enkhtuya J, Kawamoto K, Kobayashi Y, Uchida I, Rana N, Makino S.

Microbiology. 2006 Oct;152(Pt 10):3103-10.

PMID:
17005989
4.

Passive immunotherapy of Bacillus anthracis pulmonary infection in mice with antisera produced by DNA immunization.

Herrmann JE, Wang S, Zhang C, Panchal RG, Bavari S, Lyons CR, Lovchik JA, Golding B, Shiloach J, Lu S.

Vaccine. 2006 Jul 26;24(31-32):5872-80. Epub 2006 May 15.

PMID:
16790303
6.

Treatment of anthrax infection with combination of ciprofloxacin and antibodies to protective antigen of Bacillus anthracis.

Karginov VA, Robinson TM, Riemenschneider J, Golding B, Kennedy M, Shiloach J, Alibek K.

FEMS Immunol Med Microbiol. 2004 Jan 15;40(1):71-4.

7.

Anthrax capsule vaccine protects against experimental infection.

Chabot DJ, Scorpio A, Tobery SA, Little SF, Norris SL, Friedlander AM.

Vaccine. 2004 Nov 15;23(1):43-7.

PMID:
15519706
8.

[Immunogenicity of the recombinant Bacillus strains with cloned gene of biosynthesis of protective antigen against Bacillus anthracis].

Mikshis NI, Kudriavtseva OM, Bolothikova MF, Shulepov DV, Novikova LV, Popov IuA, Shchukovskaia TN, Drozdov IG, Kutyrev VV.

Mol Gen Mikrobiol Virusol. 2007;(3):15-21. Russian.

PMID:
17886469
9.

Anthrax-protective effects of yeast beta 1,3 glucans.

Kournikakis B, Mandeville R, Brousseau P, Ostroff G.

MedGenMed. 2003 Mar 21;5(1):1.

10.

Comparison of clarithromycin and ciprofloxacin therapy for Bacillus anthracis Sterne infection in mice with or without (60)Co gamma-photon irradiation.

Brook I, Giraldo DE, Germana A, Nicolau DP, Jackson WE, Elliott TB, Thakar JH, Shoemaker MO, Ledney GD.

J Med Microbiol. 2005 Dec;54(Pt 12):1157-62.

PMID:
16278429
11.

Human-derived, plant-produced monoclonal antibody for the treatment of anthrax.

Hull AK, Criscuolo CJ, Mett V, Groen H, Steeman W, Westra H, Chapman G, Legutki B, Baillie L, Yusibov V.

Vaccine. 2005 Mar 18;23(17-18):2082-6.

PMID:
15755575
12.

Bacillus anthracis: current knowledge in relation to contamination of food.

Erickson MC, Kornacki JL.

J Food Prot. 2003 Apr;66(4):691-9. Review.

PMID:
12696699
13.

Of spore opsonization and passive protection against anthrax.

Goossens PL, Sylvestre P, Mock M.

Microbiology. 2007 Feb;153(Pt 2):301-2; discussion 302-4. No abstract available.

PMID:
17259600
14.

Anthrax, toxins and vaccines: a 125-year journey targeting Bacillus anthracis.

Tournier JN, Ulrich RG, Quesnel-Hellmann A, Mohamadzadeh M, Stiles BG.

Expert Rev Anti Infect Ther. 2009 Mar;7(2):219-36. doi: 10.1586/14787210.7.2.219. Review.

PMID:
19254170
15.

Immunogenicity of a subunit vaccine against Bacillus anthracis.

Chichester JA, Musiychuk K, de la Rosa P, Horsey A, Stevenson N, Ugulava N, Rabindran S, Palmer GA, Mett V, Yusibov V.

Vaccine. 2007 Apr 20;25(16):3111-4. Epub 2007 Jan 22.

PMID:
17280756
16.

The behaviour of virulent Bacillus anthracis strain AO843 in rabbits.

Fasanella A, Scasciamacchia S, Garofolo G.

Vet Microbiol. 2009 Jan 1;133(1-2):208-9. doi: 10.1016/j.vetmic.2008.06.012. Epub 2008 Jun 21. No abstract available.

PMID:
18650035
17.

Inadvertent laboratory exposure to Bacillus anthracis--California, 2004.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2005 Apr 1;54(12):301-4.

18.

Anthrax toxin receptor 2 mediates Bacillus anthracis killing of macrophages following spore challenge.

Banks DJ, Barnajian M, Maldonado-Arocho FJ, Sanchez AM, Bradley KA.

Cell Microbiol. 2005 Aug;7(8):1173-85.

PMID:
16008584
19.

Immunisation with anthrolysin O or a genetic toxoid protects against challenge with the toxin but not against Bacillus anthracis.

Cowan GJ, Atkins HS, Johnson LK, Titball RW, Mitchell TJ.

Vaccine. 2007 Oct 10;25(41):7197-205. Epub 2007 Aug 9.

PMID:
17765365
20.

Supplemental Content

Support Center